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INTRODUCTION 
 August Bier first described "Cocainization of the spinal cord" in 1899. 
The technique has been modified since that time and has evolved into the 
modern concept of subarachnoid block (SAB). 
         Sub arachnoid block is preferred over general anaesthesia for 
endoscopic urological procedures, because it facilitates early identification of 
symptoms caused by overhydration, Trans Urethral Resection of Prostate 
syndrome and bladder perforation. 
        Commonly used local anaesthetic for sub arachnoid block is 
bupivacaine. But it has significant cardiotoxic properties. To overcome this 
side effect ropivacaine a long lasting drug with less cardiotoxity was 
discovered. 
       Local anaesthetics are available as hypobaric, isobaric and hyperbaric 
solutions. Hyperbaric solutions are often used. They tend to settle in the 
dependant portion of the sac while isobaric solution will usually stay in 
vicinity where they are injected and diffuse slowly in all directions. Hence 
isobaric solutions produce less complications compared to hyperbaric. 
       Isobaric anaesthetic injected in L2-L3 inter vertebral space provides 
dense block at lower thoracic, lumbar and sacral areas. So it is ideally suited 
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for endoscopic urological procedures which needs block upto T10 level. It 
results in partial sympathetic block with minimum hemodynamic changes. 
        Most of patients presenting for endoscopic urological surgery are 
elderly, having co-morbidities like cardiac, pulmonary, renal or some other 
condition. To reduce the adverse  effects associated with subarachnoid block 
in these patients, a suitable adjuvant to low dose local anesthetics can help to 
give the satisfactory spinal block without compromising safety. 
        Opioids are the commonly used adjuvants with local anaesthetics for 
intrathecal injections. They help to reduce the dosage of local anaesthetic 
without compromising the quality of analgesia. They also give better 
postoperative pain relief and so patient can be ambulated early which lowers 
the risk of postoperative venous thrombosis. The dose used for sub arachoid 
block is little compared to parenteral dose and it does not result in 
complications. Highly liphophilic drugs like fentanyl, sufentanil and 
alfentanil are more suitable than less liphophilic drugs like morphine. 
Fentanyl is the frequently used opioid. 
 In this prospective randomized control study, we are comparing the 
effects of intrathecal 0.5% isobaric bupivacaine with fentanyl and 0.5% 
isobaric ropivacaine with fentanyl in endoscopic urological procedures like 
Trans Urethral Resection of Prostate, Vesicolitholapaxy, Ureteroscopic Stone 
Lithotripsy and Optical Internal Urethrostomy. 
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AIMS AND OBJECTIVES 
 
 To compare intrathecal isobaric bupivacaine with fentanyl 
and isobaric ropivacaine with fentanyl in patients undergoing 
elective endoscopic urological procedures with respect to 
       1. Intraoperative hemodynamics. 
       2. To compare onset and duration of sensory and motor blockade. 
       3. Quality of analgesia.  
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NUEROANATOMY OF GENITOURINARY TRACT 
 Knowledge of neuroanatomy of genitourinary tract is important to 
appreciate the level of neuraxial block needed for urological procedures. 
 
 
 
KIDNEY 
 Afferent fibres runs through celiac, renal and superior hypogastric 
plexuses and continue in the thoracic and lumbar splanchnic nerves. 
(T10-L1).Some afferent fibres also runs with vagus nerve. This explains the 
nausea and vomiting that occurs with renal pain. 
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URETER 
 Sympathetic fibres to ureter originates from T10 through second 
lumbar segment. It synapses with post ganglionic fibres in aortic renal, 
superior and inferior hypogastric plexus. Parasympathetic is from S2, S3, S4 
sacral spinal segment. 
BLADDER AND URETHRA 
 Sympathetic nerves to bladder and urethra originates from 11th thoracic 
to the 2nd lumbar segment through superior hypogastric plexus. 
Parasympathetic nerves arise from S2,S3,S4 segments and form pelvic 
parasympathetic plexus which is joined by hypogastric plexus. 
 Parasympathetic fibres are main motor supply to bladder except trigone 
of bladder. Parasympathetic afferent carries sensation of stretch and fullness 
of bladder whereas sympathetic carries pain, touch and temperature 
sensation. 
PROSTATE 
 Prostate gland receives sympathetic supply from T11 to L3 spinal 
segments and parasympathetic from S2,S3 and S4 sacral spinal segment. 
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PENIS, SCROTUM AND DISTAL URETHRA.  
 Pudendal nerve (S2-S4) supplies penis, scrotum and distal urethra. The 
skin at the base of penis and on anterior aspect of scrotum are supplied by 
Ilioinguinal (L1) nerve and Genitofemoral (L1,L2) nerves. 
 
 
ORGAN 
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ANATOMY OF SUBARACHNOID SPACE 
 Sub arachnoid space also known as sub arachnoid cavity is a 
continuous space. It is the area between arachnoid mater and piamater. It 
extends from cerebral ventricles to sacral vertebra S2.Fibrous strands called 
trabaculae provides attachment between arachnoid and piamater. 
Contents: 
 Cerebro Spinal Fluid 
 Spinal cord 
 Conus madullaris 
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 Subarachnoid space has direct communication with brainstem through 
foramen magnum. So aseptic precautions should be followed as a must while 
performing lumbar puncture. 
SPINAL CORD 
 It lies between foramen magnum to level of first or second lumbar 
vertebra. It is 40-50cm long and 1-1.5cm thick.31 pairs of spinal nerves 
emerge from spinal cord. They contain sensory and motor nerve fibres to and 
from all parts of body. 
Membranes that surrounds spinal cord 
 Spinal cord is surrounded by three meninges. They are Piamater-
Innermost layer; it is highly vascular and covers spinal cord and brain. It 
attaches to the periosteum of coccyx. 
 Arachnoid mater-It lies outer to piamater. It is non vascular and 
attaches to duramater. It acts as a principle barrier to the migration of  
medications in and out of CSF. 
Duramater:  
 The dura mater is the outermost layer.It is present  from the foramen 
magnum upto sacrum and coccyx. The dura is being separated by the epidural  
space into peridural and extradural space. They contains fat and the vertebral 
venous plexus. In caudal analgesia technique the drug is injected into the 
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sacral hiatus which diffuses upward into the epidural space. Dural sheath 
extends to cover the nerve roots and spinal ganglia and forms the epinuerium 
of spinal nerves. 
SUBDURAL SPACE 
 It lies between dura arachnoid mater. It contains small amount of 
serous fluid that acts as lubricant. Inadvertant injection of medication into this 
space can lead to failed or total spinal. 
BLOOD SUPPLY 
Anterior spinal artery 
 Single anterior spinal artery is formed by vertebral artery at the base of 
skull. It supplies 2/3rd of anterior spinal cord. 
Posterior spinal artery 
 These are paired arteries. It is formed by posterior cerebellar arteries 
and travel down the dorsal surface of spinal cord just medial to dorsal nerves 
roots. They supply 1/3rd of posterior cord. 
 Additional supply-Intercostal and lumbar arteries. 
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Artery of adamkiewicz 
 It is a radicular artery arising from Aorta. It is large, unilateral and left 
sided artery. It supplies lower anterior 2/3rd of spinal cord. Injury to this 
artery results in Spinal Artery Syndrome. 
Surface Anatomy 
 Understanding of surface anatomy is important to identify the correct 
intervertebral space to place the needle. 
Prominent anatomical landmarks are 
 The first palpable spinous process is C2. 
 Most prominently felt vertebra is C7. 
 The tip of the scapula corresponds to T7 vertebra. 
 Tuffier’s line corresponds to body of L4 vertebra or L4-L5 interspace. 
 
SURFACE LANDMARK FOR IDENTIFYING SPINAL LEVEL 
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TUFFIER’S LINE 
 A line drawn between highest points of both iliac crests will yield 
either the body of L4 or L4-L5 interspace. 
 A line drawn across posterior superior iliac spine will cross S2. 
Locating the midline. 
 The palpable spinous processes defines midline. 
 If unable to palpate spinous process, gluteal crease may help to identify 
midline. This wont help if the patient has spinal abnormalities like scoliosis 
or kyphoscoliosis. 
 With flexion, spinous processes in the cervical and lumbar areas are 
almost horizontal. So needle should be placed slightly in cephalad direction. 
STRUCTURES PIERCED BY SPINAL NEEDLE. 
 1.SKIN-Infiltration of local anaesthetic will help to reduce the pain of 
piercing. 
 2.SUBCUTANEOUS TISSUE - It is of variable thickness in each 
patient. It is thick in obese and thin in lean patient. So identification of 
intervertebral space is difficult in obese patients. 
 3.SUPRASPINOUS LIGAMENT - The tips of spinous processes are 
joined by this ligament. 
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  4. INTERSPINOUS LIGAMENT - This ligament is thin, flat and lies 
between spinous processes.  
 5.LIGAMENTUM FLAVUM - It is a thick ligament made of elastic 
tissue. It runs from lamina to lamina. In lumbar region, the distance from skin 
to ligament is around 3-8 cm, thickness is around 6-8mm.When the needle is 
within this ligament, it will feel gripped and a distinct “give away” is felt 
while piercing this layer. 
 6.EPIDURAL SPACE - It lies outer to dura mater. It contains fat and 
blood vessels. Bloody tap occurs because of piercing these epidural veins.  
 7.SUBARACHNOID SPACE - The contents of this space are spinal 
cord and nerve roots surrounded by CSF. 
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CSF PHYSIOLOGY AND PHYSIOLOGICAL EFFECTS  
OF SPINAL ANAESTHESIA 
CSF PHYSIOLOGY 
 CSF is produced by choroid plexus from arterial blood. It is situated 
within the fourth ventricle. It is produced by a combined process of diffusion, 
pinocytosis and active transport mechanism. It is also secreted by ependymal 
cells. 
 CSF flows from lateral ventricle to third ventricle and then through 
cerebral aqueduct to fourth ventricle. Circulation of CSF is helped by 
pulsation of choroid plexus and by motion of cilia of ependymal cells. 
 Absorption of CSF into venous circulation is through arachnoid villi. A 
small amount is also absorbed by lymphatic vessels around cranial cavity and 
spinal canal. Rate of absorption depends on pressure of CSF. 
VOLUME AND PRESSURE. 
 CSF is a clear, colourless, transparent fluid. 
 Total volume is around 150-300ml.Of which around 125 ml is present 
in intracranial compartment. Volume of ventricle is 25 ml.100 ml is present 
in cranial subarachnoid space. 
 Rate of CSF production is 0.3 ml/min. 
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 CSF pressure at lumbar puncture in lateral recumbent posture is 10-18 
cm of H2O and 20-30 cm of H2O with sitting position. 
 Specific gravity of CSF is 1.003-1.009. 
FUNCTIONS. 
 It act as shock absorbant of brain. 
 It supports venous sinuses. 
 It maintains homeostasis and metabolism of CNS. 
 
Physiological Effects of Spinal Anesthesia. 
 Most of the physiological side effects of spinal anaesthesia are a 
consequence of the sympathetic blockade produced by local anesthetic block 
of the sympathetic fibers in the spinal nerve roots.  Understanding of these 
physiological effects is necessary for the safe and successful application of 
spinal anesthesia. Although some of them may be deleterious and require 
treatment, others can be beneficial for the patient or can improve operating 
conditions. 
 Most sympathetic fibers leave the spinal cord between T1 and L2. 
Although local anesthetic is injected below these levels in the lumbar portion 
of the dural sac, cephalad spread of the local anesthetic occurs. This cephalad 
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spread is of considerable importance in the practice of spinal anesthesia and 
potentially is under the control of numerous variables, of which patient 
position and baricity (density of the drug relative to the density of the CSF) 
are the most important (Greene, 1983). The degree of sympathetic block is 
related to the height of sensory anesthesia; often the level of sympathetic 
blockade is several spinal segments higher, since the preganglionic 
sympathetic fibers are more sensitive to low concentrations of local 
anesthetic. 
         The effects of sympathetic blockade involve both the actions (now 
partially unopposed) of the parasympathetic nervous system and the response 
of the unblocked portion of the sympathetic nervous system. Thus, as the 
level of sympathetic block ascends, the actions of the parasympathetic 
nervous system are increasingly dominant, and the compensatory 
mechanisms of the unblocked sympathetic nervous system are diminished. As 
most sympathetic nerve fibers leave the cord at T1 or below, few additional 
effects of sympathetic blockade are seen with cervical levels of spinal 
anesthesia. The consequences of sympathetic blockade will vary among 
patients as a function of age, physical conditioning, and disease state.  
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ANAESTHETIC CONSIDERATIONS OF SPINAL CORD 
AND NEURAXIAL BLOCKADE. 
 In adults spinal cord usually ends at L1.In infants, it ends at L3.So it is 
safe to place spinal needle below L2 in adults. 
MECAHANISM OF ACTION OF SPINAL ANAESTHETIC. 
 The anterior and posterior nerve roots pass through CSF. Local 
anaesthetics block autonomic, sensory and motor impulses. The sites of 
action are spinal nerve root and dorsal ganglion. 
 
UPTAKE AND ELIMINATION.  
 It depends on the following factors. 
         Concentration of local anaesthetic in CSF. 
         Surface area of neuronal tissue exposed to CSF. 
         Blood flow to the neuronal tissue. 
         Lipid content of tissue. 
 Spinal nerve roots are devoid of epineurium, so they are easily 
blocked. Though the site of action of local anaesthetic is not spinal cord,it 
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absorbs the drug into the pia mater and a space known as Virchow-Robbin 
which is an extension of sub arachnoid space. 
 Because of this absorption and dilution of drug by CSF, the 
concentration of the drug decreases as it moves away from the site of 
injection.  
 Initial vascular uptake of drug occurs in the blood vessels of piamater 
and spinal cord. Local anaesthetic diffuses into the epidural space along a 
concentration gradient. From there, it is absorped into epidural vasculature. 
The rate of absorption depends on the lipid solubility of the drug and the 
extent of surface area where it is exposed.  
 
DIFFERENTIAL BLOCKADE. 
 It refers to clinical phenomenon that nerve fibres with different 
functions have different sensitivity to local anaesthetic. This depends on 
factors like  length of each nerve in thecal space, depth of nerve fibre, 
distribution of Na+-K+ channels on each nerve.      
      Sympathetic nerve fibres are blocked by lowest concentration of local 
anaesthetic followed by pain, temperature, touch, proprioception and finally 
motor. 
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Clinically observed sequence of block: 
 1.Sympathetic (B- fibres : Vasodilatation, skin temperature increases). 
 2.Temperature and pain conduction(A- delta and C-fibres). 
 3.Proprioception and touch (A- gamma and A -beta fibres). 
 4.Motor functions (A-delta fibres). 
FACTORS AFFECTING LEVEL OF SPINAL BLOCK CHARECTERS 
OF INJECTED SOLUTION 
 VOLUME / DOSE - Larger the volume higher the block. 
BARICITY   
 Based on normal specific gravity of CSF (1.003-1.008) a local 
anaesthetic solution may be hypobaric, isobaric or hyperbaric. 
ISOBARIC                   HYPERBARIC                     HYPOBARIC 
 
 
v 
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 Hyperbaric means the solution is heavier than the CSF. It is generally 
prepared by adding dextrose to local anaesthetic. In head up position 
hyperbaric solution will settle down caudally. It is the most commonly used 
form. 
 Hypobaric solutions are lighter than the CSF. They move in cephalad 
direction. This can be prepared by adding sterile water to local anaesthetic. 
 Isobaric solution generally have same specific gravity as CSF. 
Generally it will stay within the area of injection. Isobaric solution may be 
prepared by mixing local aneasthetic solution with CSF in a 1:1 ratio. 
 CONCENTRATION - Higher the concentration greater the block. 
 TEMPERATURE - Very minor role, but if the solution is cold it will 
be more viscous and spread less; the opposite is true for warm solution. 
PATIENT CHARACTERISTICS. 
      AGE- Minor role; anatomical changes as ages may raise the height of 
block. 
 FACTORS INFLUENCING SPINAL LEVEL IN OLDER AGE. 
     1.Volume of CSF  is decreased. 
     2.Permeability of dura is increased. 
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     3.Myelinated fibres decrease in size and number in the dorsal and 
ventral nerve roots. 
    4. Narrowing of intervertebral space and osteophytes growth 
decreases transforaminal escape of local anaesthtic. This increases level of 
block. 
    5.Increased permeability of extra neural tissue to local anaesthetic.  
   All the above factors reduces the requirement of dose of local anaesthetic in 
older age. 
 HEIGHT- Minor role,unless extremes. 
INTRA ABDOMINAL PRESSURE 
 Engorgement of epidural veins causes a decrease in CSF volume which 
results in higher block. Conditions that may increase intra abdominal pressure 
are: pregnancy, obesity, ascites and abdominal tumours. 
SPINAL ANATOMY 
         Normal anatomical curvature influences the spread of hyperbaric 
solution. This includes natural lordosis and natural thoracic kyphosis. 
         When the drug is injected above L3 with patient in supine position, the 
drug will spread cephalad upto T4 which limits its spread. 
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PREGNANCY 
               Exaggerated lumbar lordosis in pregnancy reduces the sub 
arachnoid space volume. Also the parturients have increased sensitivity to 
local anaesthetic because of progesterone. So dose of local anaesthetic should 
be decreased to 1/3 in full term parturients. 
               Abnormal changes in anatomy of spine may decrease CSF volume 
and thereby increasing height of block. Conditions include kyphosis, 
kyphoscoliosis and lordosis. 
  
 CLINICAL TECHNIQUE.
PATIENT POSITION
 Patient position during ad
administration will impact block level.
of anaesthetic solution.
LEVEL OF INJECTION.
 The level of injection will influence spread.
if injected at L2-L3 as opposed to L5
22 
 
 
ministration and immediately after 
 This is largely the function of baricity 
 
 
 
 A greater spread will occur 
-S1. 
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TECHNIQUE OF INJECTION 
 Direction of needle- If the bevel of the needle is facing in cephalad 
direction and the drug injected will spread more than when the bevel is facing 
in lateral or caudal direction. coughing, straining or barbotage does not affect 
the height of block. 
 
SPINAL NEEDLE TYPE AND SIZE 
 Spinal needles are available in various sizes(16-30 gauge).Smaller 
needles are used in younger patients (22-25  gauge) and more thinner needles 
(25-27 gauge) are often used in older individuals which reduce the incidence 
of post dural puncture headache.  
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                Spinal needles are blunt or cutting tiped. Pencil point or blunt 
tipped needles decrease the incidence of post puncture headache. Whitacre 
needle is an example for pencil point type with rounded point and side bore. 
Quincke needle is an example for cutting needle with end bore. Sprotte is a 
side bored needle with a long opening. It has advantage of more CSF flow. Its 
disadvantage is that it can cause failed spinal.  
CHARACTERISTICS OF SPINAL FLUID. 
 Volume and density of spinal fluid will affect the height of block. 
 CSF volume is inversely related to height of block. Decreased volumes 
will have a greater spread. 
 CSF density has an impact on the spread of local anaesthetic. Baricity 
of solution is based on normal CSF density. 
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COMPLICATIONS AND CONTRAINDICATIONS OF  
SUBARACHNOID BLOCK 
COMMON IMMEDIATE 
 Hypotension. 
 Shivering 
 Temporary backache. 
 Itching (with opioids). 
UNCOMMON IMMEDIATE 
 Failure or inadequate blockade 
 Bradycardia secondary to blockade of sympathetic supply to heart. 
 Impairement of accessory muscles of respiration. 
 Horner’s syndrome(Stellate ganglion involvement). 
 Phrenic nerve paralysis(C3,C4,C5) 
UNCOMMON LATE 
 Urinary retention. 
 Dural tap headache. 
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 Neurological damage secondary to direct trauma and spinal cord 
ischemia.          
 Meningitis  
 Arachnoiditis 
CONTRAINDICATIONS 
ABSOLUTE 
 Patient refusal. 
 Local aneasthetic allergy. 
 Technical difficulties. 
 Active local infection at the site of puncture. 
RELATIVE 
 Bleeding disorders.(e.g.INR>1.2 ) 
 Hemophilia. 
 Continuing Anti coagulation. 
 Uncorrected hypovolemia.  
 Severe stenotic cardiac lesion. 
 Raised intra cranial pressure. 
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ASRA Recommendations for Spinal/Epidural Anesthesia and Anticoagulants 
 
Classifications Drugs Recommendations Investigations 
Antiplatelets Aspirin/NSAIDS 
  
Ticlopidine  
 
Clopidogrel  
 
Abciximab  
 
Eptifibatide  
None  
 
DC 14 days before  
 
DC 7 days before  
 
DC 2 days before 
 
DC 8 hours before 
None  
 
None  
 
None 
  
None  
 
None 
Anticoagulants  Warfarin  DC 4-5 days before  
Monitor patient for 24 
hours post spinal, 
epidural or removal of 
catheter  
PT/INR prior 
to needle 
placement or 
catheter 
removal; INR 
<1.5  
Heparin  S.C heparin  
 
IV heparin  
Delay until after block 
  
Delay until 1 hour 
after block; remove 
catheter 2-4 hours 
after last dose.  
>4 days check 
plt count  
 
Measure PTT  
LMWH  Ardeparin  
 
Dalteparin  
 
Enoxaparin  
 
Tinzaparin 
  
Danaparoid  
*Preop: block 10-12 
hrs after last dose; 
high dose delay 24 
hrs. (enoxaparin)  
*Postop: Twice daily 
dose delay 1st dose for 
24 hrs; 2 hr delay after 
catheter removal. 
Once daily dose 1st 
dose 6-8 hrs post op; 
remove catheter 10-12 
hr after last dose and 
wait 2 hrs till next 
dose. (enoxaparin)  
 
 
 
 
 
 
None  
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Herbal 
Preparations  
Garlic  
 
Ginkgo  
 
Ginseng  
 
Ginger  
 
Feverfew  
 
Vitamin E  
 
 
 
 
DC 5-7 days before 
surgery  
 
 
 
 
None  
New 
Anticoagulants  
Bivalirudin  
 
Lepirudin  
 
Fondaparinux  
Unknown; assess risk  
Extreme caution; 
atraumatic needle 
placement; no 
catheters  
 
 
None  
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CHOICE OF ANAESTHESIA FOR UROLOGICAL 
PROCEDURES 
 Ideal anaesthesia should provide adequate operating conditions and 
analgesia. Physiologocal disturbance should be minimal and compensatory 
mechanism should not be compromised. Bleeding must be minimized. There 
should be adequate muscle relaxation and good surgical field. 
 The technique must allow early detection of overhydration, perforation 
and hemolysis. 
 Sub arachnoid block is the method of choice as: 
1.Minimal anaesthesia is required. 
2.Patient remains awake and mentation can be assessed regularly. 
3.Respiration is minimally affected. 
4.Early recognition of complications is possible(Level to be restricted to T10). 
5.Peripheral vasodilatation helps to reduce circulatory overload. 
6.Morbidity and mortality is low. 
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 Regional anaesthesia however, does not abolish Obturator reflex 
(external rotation and  adduction of thigh secondary to stimulation of 
obturator nerve by electrocautery current through lateral wall of bladder). 
 This reflex is reliably blocked either by muscle paralysis during 
general anaesthesia or Obturator nerve block. 
 General anaesthesia is usually given in major surgeries such as 
nephrectomy, cystectomy and renal transplantation.            
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ANAESTHETIC IMPLICATIONS OF UROLOGICAL                          
PROCEDURES 
 This study was done in Trans Urethral Resection of Prostate, 
Vesicolitholaplaxy, Ureteroscopic stone lithotripsy and Optical Internal 
Urethrostomy. 
URETEROSCOPIC STONE LITHOTRIPSY 
 Here mid and lower ureteric stones are broken and it is removed 
through the ureteroscope. Simultaneously an irrigating solution 0.9% normal 
saline flows into the surgical site through the channel in the ureteroscope. 
Thus broken stones are washed out and clear surgical field is maintained. 
TRANS URETHRAL RESECTION OF PROSTATE 
 A resection of benign hypertrophic prostate tissue by a movable 
electrocautery cutting wire loop located at the end of urethroscope. 
Simultaneously 1.5 % glycine at a pressure of less than 70 cm of H2O is 
irrigated through the ureteroscope to distend the bladder. This helps to wash 
away blood and tissue debris. 
VESICOLITHOLAPAXY 
 Here bladder stones  are broken and subsequently removed through a 
cystoscope.0.9% normal saline is used as irrigating fluid here. 
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OPTICAL INTERNAL URETHROSTOMY. 
 It is done for stricture urethra. Endoscopy provides a direct vision of 
stricture. A filiform is passed through the stricture and used as a guide during 
lysis. A catheter is left in place for a short time to prevent bleeding and 
pain.0.9% normal saline is used as irrigating fluid. 
INTRA OPERATIVE COMPLICATIONS. 
TURP SYNDROME. 
 Trans Urethral Resection of Prostate often opens the extensive network 
of venous sinuses and potentially allows systemic absorption of irrigating 
fluid. The absorption of larger amount of fluids (>2 L) results in water 
intoxication, hyponatremia, hypoosmolality, cerebral edema, pulmonary 
edema, hemolysis, hypoxia and solute toxicity(hyperglycinemia and hyper 
ammonemia). 
Prevention. 
 Irrigation fluid should be at a maximum height of 60 cm(2 feet) above 
the level of pubic symphysis. This creates hydrostatic pressure around 60 to 
70 cm of H20 which is the maximum allowable limit.  
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Treatment 
 Treatment depends on early recognition and severity of symptoms. 
Symptomatic hyponatremia (Na+<120 mEq/lit) resulting in seizures or coma 
should be treated with hypertonic saline.Seizure activity terminated with low 
dose of midazolam (3-4 mg).Fluid restriction, loop diuretics, mannitol, 
ionotropic agents or even dialysis can be done appropriately. Endotracheal 
intubation is generally advised to prevent aspiration. 
HYPOTHERMIA. 
 Large volume of irrigating fluid at room temperature can be a major 
source of heat loss. In regional anaesthesia there is redistribution of body heat 
from deep to superficial tissue. In the area of block ability to shiver is lost and 
metabolic response to trauma is obtunded. This collectively causes 
hypothermia. 
 Hypothermia manifests as altered mental status, shallow respiratory 
pattern, cardiac rhythm disturbances(SVT, AF, Ventricular ectopics) and 
delayed recovery from anaesthesia. Hypothermia also leads to metabolic 
disturbances, reduced liver and renal perfusion and induce coagulopathy.  
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Treatment 
 Mild hypothermia is corrected with gradual spontaneous rewarming 
with a blanket and warm IV fluids.But severe hypothermia needs active 
warming methods along with continuous core temperature monitoring. 
OVER HYDRATION 
       The syndrome of over hydration consist of triad of signs –bradycardia, 
elevated SBP and DBP with increased pulse pressure and cerebral agitation 
and depression .When over hydration is suspected, immediate measurement 
of serum Na+ and serum osmolality should be done. When patient develops 
neurological symptoms prompt intervention is required. 
BLADDER PERFORATION 
 This can be due to instrumentation or over distension of bladder. 
Patients present with abdominal pain radiating to shoulder or suprapubic 
region, rigidity, nausea, vomiting ,diaphoresis, bradycardia, hypertension and 
shock like picture. Extra peritoneal rupture can be treated conservatively. 
Intra peritoneal rupture requires surgical repair. 
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BLOOD LOSS 
 Visual estimation of blood loss is difficult due to dilution of blood with 
irrigating fluid. Warning signs like tachycardia and hypotension are masked 
by bradycardia and hypertension of over hydration syndrome.  
           The way to calculate true blood loss is to collect all of the irrigating-
blood mixture and to measure its hemotocrit: 
   Blood loss (ml)=Hb of irrigating fluid (gm/ml)  ×Volume of irrigating fluid 
                                 Patient’s Hb (gm/lit) 
Methods of quantifying blood loss are 
 1.Radioactive labelling of RBC’s 
 2.Alteration in electrical conductivity. 
 3.Calorimetric method. 
LITHOTOMY POSITION 
 Lithotomy position is the most commonly used position for endoscopic 
urological procedures. 
  Two persons are required to safely move the patients leg 
simultaneously up or down.
simultaneously and thighs are flexed about 90 degree to abdomen and 
outwardly rotated. 
 
Comp
Peripheral nerve injury
 Common peroneal nerve (L4,L5,S1,S2).
inloss of dorsiflexion of foot and results in foot drop.
           Obturator nerve(L2,L3,L4).
compression of this nerve and it leads to paralysis of adductors of thigh.
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 Both the legs are elevated and flexed 
lications of lithotomy position 
 
-Injury to this nerve results 
 
-Acute flexion of the thigh to groin causes 
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          Saphenous nerve(L2,L3,L4).-Compression of medial aspect of the leg 
against the knee brace results in sensory loss to medial side of thigh. 
          Brachial plexus injury and compartment syndrome of lower extremity 
are also reported. 
Cardiorespiratory compromise 
 Functional residual capacity decreases and predisposes to atelectasis 
and hypoxia. Lithotomy position results in 18% reduction in vital capacity. 
Elevation of the legs increases venous return and it may exacerbate 
congestive cardiac failure. Rapid lowering of leg acutely decreases venous 
return and results in hypotension. 
Venous stasis 
          Stasis occurs at points of compression by equipments or at the groin 
due to thigh flexion. Patients with varicose veins are at high risk. Lithotomy 
position more than 15 mins have to be protected by elastic stockings. 
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METHODS OF PAIN MEASUREMENT 
 Pain is defined by International association as “an unpleasant sensory 
and emotional experience associated with actual or potential tissue damage or 
described in the terms of such damage”. 
 Methods of pain measurement includes 
            1.Visual analogue pain scale. 
  2.Verbal rating scale. 
  3.Mc Gill pain Questionnaire. 
  4.The Descriptor Differential scale. 
VISUAL ANALOGUE PAIN SCALE ADVANTAGES 
 1.Simple,efficient,minimally intrusive measure of pain intensity. 
           2.Widely used in clinical as well as  research settings. 
           3. Provided that adequate clear instructions are given to the patient, its 
conceptual simplicity. 
DISADVANTAGES 
           1. Bias of expectancy for change and reliance on memory. 
 2. It is assumed that pain is a unidimensional experience.  
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PHARMACOLOGY OF BUPIVACAINE 
 Bupivacaine (MARCAINE, SENSORCAINE), is a widely used amide 
local anesthetic; its structure is similar to that of lidocaine except that the 
amine-containing group is a butyl piperidine 
 Bupivacaine is an amino amide local anaesthetic with a slow onset. It 
is  long acting and suitable for procedures lasting 2 – 2.5 hrs. It was first 
synthesized by Ekenstam in 1957 and was used clinically in 1963. 
 
 It is available as hyperbaric solution in concentrations of 0.5% and 
0.75% with dextrose 8.25%.Available Isobaric solutions are in concentrations 
of 0.5% and 0.75%.Maximum dose is 2mg/kg body weight. 
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PHYSICO-CHEMICAL PROFILE. 
Molecular weight(base) 
pKa 
Solubility in 
  Alcohol 
  Water 
Octonol/water partition coefficient 
Lipid solubility 
Plasma protein binding 
Anaesthetic index 
288 
8.16 
 
1 in 8 
1 in 25 
High 
28 
95%         
3.0-4.0       
 
MECHANISM OF ACTION  
 Local anesthetics cause reversible blockade of impulse conduction 
along nerve axons and other excitable membranes. This action is by direct 
interaction of drug with voltage gated Na+ channels. This can be used 
clinically to block pain sensation from - or sympathetic vasoconstrictor 
impulses to - specific areas of the body. Bupivacaine also reduces the 
permeability of the resting nerve membrane to potassium as well as sodium 
ions. 
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PHARMACODYNAMICS 
       Bupivacaine by virtue of its pharmacological effects, has a stabilizing 
action on all excitable membranes. In the central nervous system, stimulation 
can occur producing restlessness, tremors and convulsions in over dosage. 
Bupivacaine can also causes a reduction of automaticity in the heart. 
 
PHARMACOKINETICS  
ABSORPTION 
 The absorption depends on: 
        1. Site of injection(intercostals>caudal>epidural>brachial plexus > 
subcutaneous) 
        2. Dose- the peak blood concentration increases with increase in dose. 
       3. Presence of vasoconstrictors-delays absorption. 
 
DISTRIBUTION 
       Bupivacaine is 95% protein bound to albumin and alpha-1 acid 
glycoprotein. 
 
METABOLISM 
       Occurs in liver by N-dealkylation, primarily to pipecolyxylidine. N-
desbutyl bupivacaine and 4-hydroxy bipivacaine are the other metabolites 
produced. 
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EXCRETION 
 Excretion is through urine(5% as pipecolyxylidine and 16% as 
unchanged form).The clearance is 0.47 l/min and elimination half life is 162 
mins. 
 
EFFECTS IN CVS 
         It has marked cardiotoxic properties. It can bind to myocardial proteins 
and thus decreases the rate of increase of phase 0 during the cardiac action 
potential. In higher concentration, the peripheral vascular resistance and 
myocardial contractility are reduced and this can lead to cardiovascular 
collapse. 
 
EFFECTS IN CNS 
         In CNS it causes reversible neural blockade. It has characteristic 
biphasic effect in CNS. Intial excitation is caused by inhibition of inhibitory 
interneuron pathways in cortex. In higher doses both facilitatory and 
inhibitory pathways are depressed. 
 
ADVERSE REACTIONS 
CNS 
           Excitation characterized by restlessness, anxiety, dizziness, tinnitus, 
blurred vision or tremors proceeding to convulsions, followed by drowsiness, 
unconsciousness and cardiac arrest. 
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CVS 
           Cardiotoxicity effects are due to high lipid solubility and high protein 
binding properties of the drug. Accidental intravenous injection causes 
dysrhythmias, atrioventricular block, ventricular tachycardia and ventricular 
fibrillation. 
 
ALLERGY 
            Allergy is extremely rare. It manifests as urticaria, pruritis, 
angioneurotic edema etc. 
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 PHARMACOLOGY OF ROPIVACAINE
 Ropivacaine is a member of amino amide class of local anaesthetic.
The amino ethylamide ropivacaine is the 
pipecoloxylidide. Ropivaca
Mepivacaine. 
STRUCTURE 
MECHANISM OF ACTION
 Local anesthetics block conduction by decreasing or preventing the 
large transient increase in the permeability of excitable membranes to Na
that normally is produced by a slight depolarization of the membrane  
(Strichartz and Ritchie, 1987
direct interaction with voltage
progressively develops in a nerve, the threshold for electrical excitability 
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). This action of local anesthetics is due to their 
-gated Na+ channels. As the anesthetic action 
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gradually increases, the rate of rise of the action potential declines, impulse 
conduction slows, and the safety factor for conduction decreases. These 
factors decrease the probability of propagation of the action potential, and 
nerve  
PHARMACOKINETICS 
 Molecular weight  328.89 
 pKa    8.1 
 t1/2    111 
 Clearance   0.7 l /min 
 Protein binding           94% 
 Lipid solubility  Intermediate  
ABSORPTION 
 Absorption is similar to Bupivacaine. 
DISTRIBUTION 
 Protein bounding  in plasma is about 94% predominantly to alpha 1 
acid glycoprotein; the volume of distribution is 52-66 l. 
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  METABOLISM 
    By aromatic hydroxylation Ropivacaine is metabolized in liver 
through cytochrome CYP1A2 to  the major metabolite 3-hydroxy-
ropivacaine.4-hydroxy-ropivacaine and 4-hydroxy-dealkylated-ropivacaine 
are also produced. 
EXCRETION 
 The clearance is 0.44-0.82 l/min. The elimination half life is 59-173 
mins. 86% of dose is excreted in urine,1% unchanged. 
EFFECTS IN CVS 
 Ropivacaine is less cadiotoxic than Bupivacaine. It has biphasic 
vascular effect, causing vasoconstriction at low but not at high 
concentrations. In higher concentrations, the peripheral vascular resistance 
and myocardial contractility are decreased. 
EFFECTS IN CNS 
 It causes reversible neural blockade. Has similar biphasic effects as 
Bupivacaine. 
 Maximum dose is 3mg/kg body weight. 
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ADVERSE REACTIONS. 
 Allergy to amide linked local anaesthetics are extremely rare. 
Bronchospasm, urticaria and angioneurotic edema may occur. 
 Treatment of allergic reactions is with oxygen, injection of epinephrine 
and hydrocortisone. 
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 PHARMACOLOGY OF FENTANYL
 A tertiary amine which is a synthetic phenylpiperidine  derivative.4 
anilinopiperidines that are structurally related to pethidines,
 It act at µ receptors as a agonist.
80-100 times more potent than M
STRUCTURE 
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 It is more specific, shorter acting and
orphine. 
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PREPARATION 
 It is available as a clear solution for injection containing  
50 micrograms/ml Fentanyl citrate. 
ROUTE OF ADMINISTRATION. 
 Oral, parenteral (iv, im), neuraxial (subarachnoid and epidural), trans 
mucosal, transdermal. 
MECHANISM OF ACTION 
 It is a highly selective mu-agonist which specifically appears to be 
involved in the mediation of analgesia. Opioids appear to exert their effects 
by interacting with pre-synaptic Gi-protein receptors. 
PHARMACOLOGY OF SPINAL FENTANYL 
 Dose  5-25 µg 
 Onset   5-15 mins 
 Duration   2-4 hrs. 
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PHARMACOKINETICS 
METABOLISM 
 Fentanyl is extensively metabolized by N-demethylization producing 
Norfentanyl, which is structurally similar to Normeperidine. It is excreted by 
the kidneys. 
   pKa 
   Molecular weight 
   Bound to plasma protein 
   T1/2µ 
   T1/2 α 
  T1/2β 
  Clearance 
  Hepatic extraction ratio 
  Octanol-water partiant coefficient 
8.4 
286 
84% 
1-2 mins 
10-30 mins 
2-4 hrs 
10-20ml/kg/min 
0.8-01. 
817 
 
 
 
51 
 
CLINICAL PROPERTIES 
 Minimal CSF spread. 
 Rapid onset. 
 Short duration. 
 Low CSF solubility. 
 Decreased side effects. 
 Rapid analgesia. 
EFFECTS IN CVS: 
 Most significant effect is bradycardia caused by vagal stimulation. It 
does not affects cardiac output, mean arterial pressure, pulmonary capillary 
wedge pressure, pulmonary and systemic vascular resistance. 
EFFECTS IN RS: 
 Potent respiratory depressant. It decreases both respiratory rate and 
tidal volume. It also diminishes ventilator response to hypoxia and 
hypercapnia. Chest wall rigidity(wooden chest phenomenon) may occur. 
EFFECTS IN CNS 
       Analgesia, euphoria, sedation, hypnosis, miosis, nausea and vomiting.  
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EFFECTS IN GI TRACT 
 Delays gastric emptying, biliary colic. 
ENDOCRINE : Attenuation of stress response. 
ADVERSE EFFECTS 
 Pruritis, sedation, nausea, vomiting, apnea, urinary retention, seizures 
and chest wall rigidity may occur. 
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REVIEW OF LITERATURE 
1. Randomized double-blind comparison of ropivacaine-fentanyl and 
bupivacaine-fentanyl for spinal anaesthesia for urological surgery.          
Acta Anaesthesiol Scand. 2005 Nov;49(10):1477-82. 
 
 Lee YY, conducted a prospective randomized double-blind study 
among 34,ASA 1-3 patients; planned for urological surgery with combined 
spinal epidural technique. He administered 10 mg of plain ropivacaine with 
15 µg of fentanyl and 10 mg of plain bupivacaine with 15 µg of fentanyl two 
groups. And with his observation he concluded that sensory block upto T10 
and motor blockade was attained in both groups in almost similar time. The 
duration of motor blockade was shorter in ropivacaine group with median of 
126 mins and P=0.003.Hemodynamic changes did not show significant 
difference between these groups.    
2. Spinal anaesthesia: comparison of plain ropivacaine, bupivacaine and 
levobupivacaine for lower abdominal surgery. Acta Anaesthesiol Belg. 
2008;59(2):65-71 
 Mantouvalou, performed a randomized control study with 120 patients 
(ASA 1-3) of 3 groups (40 each), to compare the effects of plain ropivacaine, 
bupivacaine and levobupivacaine for lower abdominal surgery. Group A,B 
and C received 15 mg of isobaric bupivacaine, ropivacaine and 
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levobupivacaine respectively. The onset and duration of sensory block upto 
T8, maximum spread of sensory block, onset, intensity and duration of motor 
block and any adverse effects were observed and recorded. Patients receiving 
bupivacaine showed faster onset of motor block than ropivacaine but almost 
the same as of levobupivacaine (P<0.05). Ropivacaine provided shorter 
duration of both motor and sensory block than other two drugs (P<0.05). 
Bupivacaine group experienced more side effects like hypotension and 
bradycardia. 
3. Comparison of ropivacaine and bupivacaine for intrathecal anesthesia 
during outpatient arthroscopic surgery. J Clin Anesth. 2006 
Nov;18(7):521-5. 
 Boztuğ N conducted randomized single blinded study with 90 patients 
scheduled for outpatient arthroscopic knee surgery. The patients were 
randomly divided into Group R (15 mg isobaric ropivacaine) and Group B 
(7.5 mg isobaric bupivacaine).The drugs were administered with patient in 
lateral recumbent position at L3-L4 space with 27 G Quinke spinal needle. 
The study showed that the onset time of sensory block upto L1 was shorter in 
Group R. Complete motor block was observed in 40 patients with ropivacaine 
and in 45 patients with bupivacaine. First ambulation, first urination and 
discharge time were similar in both groups. Ropivacaine provides higher 
cephalad spread of sensory block(P<0.05). 
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4.Comparison of intrathecal isobaric bupivacaine-morphine and 
ropivacaine-morphine for Caesarean delivery. Br J Anaesth. 2003 
May;90(5):659-64 
 Oğün CO : This study included 50 healthy parturients undergoing 
Caesarean delivery. Twenty five patients in Group RM received intrathecal 
15 mg ropivacaine and 150 microgram morphine and twenty five patients in 
Group BM received 15 mg bupivacaine and 150 microgram morphine. 
Sensory and motor blockade, haemodynamics, postoperative pain relief, fetal 
outcomes and parameters, and side-effects were observed. 
 Complete motor block was attained in a shorter time in BM group than 
the RM group (P<0.05). The time for the block to drop to the S2 dermatome 
were similar in both groups (P>0.05). Time of first perception of pain and the 
need for consumption of tenoxicam were similar in both groups 
(P>0.05).Fetal outcome was observed in terms of APGAR scores at 1 and 5 
min and were similar in both groups   (P>0.05). The most common side 
effects observed were hypotension and pruritis. 
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5.Comparison of the effects of intrathecal ropivacaine, levobupivacaine, 
and bupivacaine for Caesarean section. Br J Anaesth. 2003 
Nov;91(5):684-9. 
 Gautier P conducted a study to compare the effects of ropivacaine, 
levobupivacaine and bupivacaine by combined spinal-epidural technique in 
caesarean section. Ninety parturients were selected and they randomly 
received isobaric bupivacaine 8 mg, levobupivacaine 8 mg or ropivacaine 12 
mg, Sufentanyl 2.5 micro gram was added as a common additive. 
Effectiveness of the drug was assessed on the basis of providing adequate 
sensory block upto T4 and requirement of intraoperative epidural top-ups. 
The study showed that effective anaesthesia was attained in 97,80 and 87 % 
of parturients in bupivacaine, levobupivacaine and ropivacaine groups 
respectively.(P<0.05).Bupivacaine also provided longer duration of sensory 
and motor blockade(P<0.05%).   
6.Intrathecal sufentanil or fentanyl as adjuvants to low dose bupivacaine 
in endoscopic urological procedures. 
 Gupta SSampley conducted a  prospective,randomized,double-blinded 
study to compare the effects of sufentanil and fentanyl as additive to low dose 
bupivacaine in spinal anaesthesia in endoscopic urological procedures.A 90 
patients (40-80 years) were selected and grouped as A ,B and C.Group A ,B 
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and C are provided with intrathecal 0.5% of 7.5 mg hyperbaric bupivacaine 
,or the same by adding sufentanil 10µg and fentanyl 25 µg respectively. 
Quality of anaesthesia and analgesia are observed. Maximum level of 
attainment of sensory block was higher in Group A. Sufentanyl provided 
better and prolonged analgesia. But motor block intensity and duration was 
better with Group A.  
7.Neuraxial anesthesia versus general anesthesia for urological surgery: 
systematic review. 
 Barbosa FT  This study was conducted in an idea to choose best 
anaesthetic technique for urological surgeries.Neuraxial blockade and general 
anaesthesia were compared.They collected 2720 study datas from the 
Cochrane Central Register of Controlled Trials in the Cochrane Library 
(Issue 10, 2012), Medline via PubMed (1966 to October 2012), Lilacs (1982 
to October 2012), SciELO and EMBASE (1974 to October 2012)  and were 
analysed..  Randomized controlled trials (RCT) studies were included..  
Among these studies11 fulfilled the inclusion criteria. The study validity was: 
Jadad score &#x3E; 3 in one RCT; seven RCTs with unclear risk of bias as 
the most common response; and five RCTs not fulfilling half of the Delphi 
list items. The frequency of mortality was not significant between study 
groups in three RCTs. Meta-analysis was not performed. And they concluded  
58 
 
that the evidence available cannot prove that neuraxial anesthesia is more 
effective and safer than general anesthesia for urological surgery. 
8.Comparison of equipotent doses of ropivacaine-fentanyl and 
bupivacaine-fentanyl in spinal anaesthesia for lower abdominal surgery. 
 Koltka K  A randomized double blinded study to compare the effects 
of plain ropivacaine and bupivacaine with fentanyl intrathecally for lower 
abdominal surgeries. 52 ASA I to II male patients posted for lower abdominal 
surgery were randomly assigned to receive plain ropivacaine 19.5 mg with 
fentanyl 20µg (group R, n =26) or plain bupivacaine 13 mg with fentanyl 20 
µg  (group B, n =26) intrathecally. The level and intensity of sensory block, 
level and duration of motor block, time to ambulate and patient satisfaction 
about pain relief were observed and recorded.Both groups achieved sensory 
block upto T10 or higher. Bupivacaine provided significantly higher sensory 
block (T4 [T3 to T7] vs T7 [T4 to T9], P <0.05). Ropivacaine provided 
shorter duration of motor block (Bromage score >0) (139+/-39 minutes vs 
group B 182+/-46 minutes, P <0.05). The duration and intensity of complete 
motor block (Bromage score=3) were also shorter in group R (90+/-25 
minutes vs 130+/-40 minutes, P <0.05). And they concluded that intrathecal 
plain ropivacaine 19.5 mg plus fentanyl 20 µg provided a lower level of 
sensory block and a shorter duration of motor block than bupivacaine 13 mg 
plus fentanyl 20µg in lower abdominal surgery. 
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9.Intrathecal 0.75% Isobaric Ropivacaine Versus 0.5% Heavy 
Bupivacaine for Elective Cesarean Delivery: A Randomized Controlled 
Trial Surjeet Singh 
  This randomized control trial was done to compare the intrathecal 
efficacy and safety of 0.75% isobaric ropivacaine  with 0.5% heavy 
bupivacaine in in patients undergoing Caesarean delivery.They selected 46 
parturients of ASA grade I-II planned for elective cesarean delivery. The 
parturients were randomized to receive either intrathecal 12.5 mg of0.5% 
hyperbaric bupivacaine or 24 mg of 0.75% plain ropivacaine .Intraoperative 
vital parameters,intensity of sensory and motor nerve blockade, neonatal 
outcome and maternal adverse effect such as hypotension,bradycardia, 
nausea, vomiting, shivering or pruritis  were observeed evaluated.Baseline 
variables were similar in the 2 groups (p-value>0.05. The time to achieve 
adequete sensory block to T10 (3.2 ± 1.5 vs 2.5 ± 1.3 minutes)  or to the 
maximal level (9.8 ± 3.1 vs 7.9 ±2.3 minutes) was longer in the ropivacaine 
group (p-value 0.048) but the median maximal level of sensory block was 
similar between the two groups (p-value>0.05).Ropivacaine gives shorter 
duration of sensory block (160.5± 22.2 vs 182.3±30.5 minutes) (p-value 
0.03). Duration of motor block was also comparitively shorter in ropivacaine 
group (112.5 ± 45 vs 165.3± 26) (p-value 0.004). Neonatal outcome was 
similar in both groups.They concluded that isobaric ropivacaine  can be used 
as an  effective and safe alternative to bupivacaine.    
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MATERIALS AND METHODS 
 This is a prospective randomized control study.This study was 
conducted at the Institute of Urology in Rajiv Gandhi Government General 
Hospital between August 2014 and September 2014.This study was done in 
100 patients presenting for elective endoscopic urological procedures of ASA 
physical status 1 and 2. Ethical committee approval and informed written 
consent from patients involved in this study are obtained before starting this 
study. 
INCLUSION CRITERIA. 
  Age    : >18 years  
  Weight      :  Body Mass Index <30kg/m2 
  ASA    : 1 and 2. 
  Surgery      :  Elective 
  Mallampatti scores   :  I and II 
 Who have given valid informed written consent. 
 EXCLUSION CRITERIA. 
 Not satisfying inclusion criteria 
 Patient posted for emergency surgery 
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 Patients with difficult airway 
 Lack of informed written consent 
 Pregnant female 
 H/O any seizures and any neurological deficit 
 Severe renal, hepatic, respiratory and cardiovascular disease 
 Severe coagulopathy 
 Allergy to local anaesthetics 
STUDY DESIGN 
 Prospective randomized control study, single blinded. 
STUDY POPULATION. 
 100 Patients. 
GROUP 1 
 Patients in this group received intrathecal 11.25 mg (2.25ml) of 0.5% 
isobaric Bupivacaine and 12.5 µg (0.25 ml) of Fentanyl at L2-L3 
intervertebral space in sitting position. 
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GROUP 2 
 Patients in this group received intrathecal 11.25 mg (2.25 ml) of 0.5% 
isobaric Ropivacaine and 12.5 µg (0.25 ml) of Fentanyl at L2-L3 
intervertebral space in sitting position. 
MATERIALS 
 25 gauge Quincke spinal needle. 
 Drugs: 0.5% Isobaric Bupivacaine and 0.5% Isobaric 
Ropivacaine(Ropin 0.5 in 10 ml ampoule). 
           Inj. Fentanyl 50 µg/ml, 2ml ampoule 
           Emergency drugs and crystalloids. 
 Monitors:ECG, NIBP, SPO2, PR. 
PRE ANAESTHETIC EVALUATION. 
 Patients included in this study underwent pre anaesthetic evaluation 
which included the following 
HISTORY 
 History of underlying comorbid illnesses like diabetes, hypertension, 
bronchial asthma, renal failure and seizures. 
 Previous history of surgery and any anaesthesia exposure noted. 
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 History of any allergy to drugs noted. 
PHYSICAL EXAMINATION 
 General examination with regard to consiousness, orientation,head to 
toe examination and vital signs are assessed. 
 Height and weight noted. 
 Systemic examination of Cardiovascular system,respiratory system, 
central nervous system and abdominal examination done. 
 Local examination of spine and airway assessment done. 
INVESTIGATIONS 
 Complete hemogram (Hb%, RBC count, WBC count, Differential 
count, Platelet count) 
 Random blood sugar, Blood urea, Serum creatinine. 
 Serum electrolytes 
 Bleeding time, Clotting time 
 Urine albumin, sugar. 
 ECG, Chest Xray 
 Echo(if necessary). 
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 Patients who satisfied the inclusion criteria are explained about the 
nature of study and anaesthetic technique and informed written consent was 
obtained. 
PRE ANAESTHETIC PREPARATION.  
 1.Anaesthetic machine is checked before starting the procedure. 
 2.Ensure the availability of working laryngoscope and endotracheal 
tubes of various sizes. 
 3.Make sure that the essential emergency drugs are available. 
 4.Ensuring the operating table tilts are corrected. 
 5.Obtain intravenous access(18 G cannula) and preload with 500 ml ol 
crystalloid (Normal saline). 
 6.Connect monitors to the patient.(ECG,PR,NIBP,SPO2,RR) and base 
line vitals are observed. 
TECHNIQUE 
 Under strict aseptic precaution,patient in sitting position with flexion 
of spine and neck, lumbar region is painted and draped. L2-L3 intervertebral 
space is identified by using Tuffier’s line. Then skin is infiltrated with 2 ml of 
2% lignocaine. By midline approach 25 G Quincke’s needle is inserted into 
subarachnoid space.After confirming free flow of clear CSF,11.25 mg of 
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0.5% isobaric Bupivacaine / Ropivacaine with 12.5 microgram Fentanyl is 
injected. 
OBSERVATION 
VITAL SIGNS 
 Patient’s pulse rate,SBP,DBP,MAP,SpO2 and respiratory rate are 
observed at 1,3,5,10,15,30,45,90 and 120 mins after subarachnoid blockade. 
 Common side effects observed after sub arachnoid block are 
hypotension and bradycardia. Hypotension is defined as a drop of systolic 
blood pressure of more than 20% from baseline (or) systolic BP of less than 
90 mm of hg. It is managed with Inj. Ephedrine intravenously in increments 
of 6 mg as necessary. 
 Bradycardia is defined as heartrate of <60/min and it is managed with 
Inj. Atropine 0.6 mg . 
 Respiratory depression is defined as a respiratory rate <8/min (or) 
oxygen saturation of <85% and it is managed with bag and mask ventilation 
or endotracheal intubation and IPPV if warranted. 
SENSORY BLOCK. 
 1.Time of onset ( Time taken to attain T10 dermatomal level). 
 2.Duration of block.(Time of complete resolution of block). 
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MOTOR BLOCK. 
1.Onset of motor block. 
 Degree of motor block is assessed by modified Bromage scale at 5 
mins interval. 
 0 =able to raise straight leg against resistance i.e. no detectable motor 
block. 
 1=unable to raise straight leg but able to flex knee. 
 2=unable to flex knee but able to flex ankles. 
 3= unable to move hip, knee or ankle. 
2. Duration of motor block. 
POST OPERATIVE VAS SCORE. 
 Quality of analgesia is assessed by post operative visual analogue 
scale. It is observed  hourly at 1,2,3,4,5,6 hrs in post operative room. The 
VAS is a 10 cm horizontal scale marked with “no pain” at one end and 
“worst pain” at other end. The patient is asked to mark on this line according 
to the intensity of pain they feel. 
  
  
 
 
RESULTS 
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RESULTS 
 This study was conducted in Institute of Urology, Rajiv Gandhi Govt. 
General Hospital, Chennai during August 2014 and September 2014. 
       This study was conducted in elective endoscopic urological procedures 
URSL,VL,TURP and OIU. The patients were randomized into two groups-
Group 1 and Group 2.The trial numbers are 50 in each group. 
 Group 1- Isobaric Bupivacaine with Fentanyl. 
 Group 2 –Isobaric Ropivacaine with Fentanyl. 
 The following results are obtained from this study: 
 
AGE AND BMI DISTRIBUTION 
 Age and BMI distribution in both groups are shown in the table below. 
The values are similar in both groups. The Student T-test done on the values 
revealed no statistical significance.  
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T-Test 
Table 1 
 
                                              
Table 2 
 
 P-value for age=0.520-Not significant. 
 P-value for BMI=0.081-Not significant. 
  
Group Statistics
50 46.30 14.535 2.056
50 44.48 13.673 1.934
50 23.23 1.620 .229
50 23.78 1.480 .209
GROUP
GROUP 1
GROUP 2
GROUP 1
GROUP 2
AGE
BMI
N Mean Std. Deviation
Std. Error
Mean
Independent Samples Test
.331 .566 .645 98 .520 1.820 2.822 -3.780 7.420
.645 97.636 .521 1.820 2.822 -3.781 7.421
.992 .322 -1.766 98 .081 -.548 .310 -1.164 .068
-1.766 97.220 .081 -.548 .310 -1.164 .068
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
AGE
BMI
F Sig.
Levene's Test for
Equality of Variances
t df Sig. (2-tailed)
Mean
Difference
Std. Error
Difference Lower Upper
95% Confidence
Interval of the
Difference
t-test for Equality of Means
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SEX DISTRIBUTION 
SEX  GROUP 
 The sex distribution among the patients in two groups are analysed 
below.  
Table 3 
 
Table 4 
 
 P-value of Chi-Square test=0.513-Not significant. 
 
Crosstab
33 37 70
66.0% 74.0% 70.0%
17 13 30
34.0% 26.0% 30.0%
50 50 100
100.0% 100.0% 100.0%
Count
% within GROUP
Count
% within GROUP
Count
% within GROUP
MALE
FEMALE
SEX
Total
GROUP 1 GROUP 2
GROUP
Total
Chi-Square Tests
.762b 1 .383
.429 1 .513
.764 1 .382
.513 .257
.754 1 .385
100
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
0 cells (.0%) have expected count less than 5. The minimum expected count is 15.
00.
b. 
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ASA  GROUP 
 ASA 1 and 2 groups patients are only included in this study. 
 ASA 1-No systemic organic physiological, biochemical or psychiatric 
disturbance. 
 ASA 2-Mild to moderate systemic disturbances caused by the disease 
and has to be treated surgically or other pathophysiology (diabetic mellitus, 
mild hypertension, anemia, old age, obesity). 
Table 5 
 
Table 6
 
P value of Chi-Square test=0.139-Not significant. 
Crosstab
29 37 66
58.0% 74.0% 66.0%
21 13 34
42.0% 26.0% 34.0%
50 50 100
100.0% 100.0% 100.0%
Count
% within GROUP
Count
% within GROUP
Count
% within GROUP
I
II
ASA
Total
GROUP 1 GROUP 2
GROUP
Total
Chi-Square Tests
2.852b 1 .091
2.184 1 .139
2.872 1 .090
.139 .069
2.824 1 .093
100
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
0 cells (.0%) have expected count less than 5. The minimum expected count is 17.
00.
b. 
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SURGERY  GROUP 
 Patients undergoing  various endoscopic urological surgeries are 
plotted and analysed below. 
Table 7 
 
URSL-Ureteroscopic Stone Lithotripsy. 
VL-Vesicolitholapaxy. 
TURP-Trans Urethral Resection of Prostrate. 
OIU-Optical Internal Urethrostomy. 
 
 
 
 
Crosstab
28 30 58
56.0% 60.0% 58.0%
5 4 9
10.0% 8.0% 9.0%
10 12 22
20.0% 24.0% 22.0%
7 4 11
14.0% 8.0% 11.0%
50 50 100
100.0% 100.0% 100.0%
Count
% within GROUP
Count
% within GROUP
Count
% within GROUP
Count
% within GROUP
Count
% within GROUP
URS
VL
TURP
OIU
SURGERY
Total
GROUP 1 GROUP 2
GROUP
Total
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Table 8 
 
 P-value of Chi-Square test=0.758-Not significant. 
  
  
SENSORY BLOCK. 
 Time taken for onset (upto T10 level) and duration of sensory block for 
patients in both groups are compared and subjected to Student T-test.  
T-Test 
Table 9 
 
Chi-Square Tests
1.180a 3 .758
1.191 3 .755
.292 1 .589
100
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
2 cells (25.0%) have expected count less than 5. The
minimum expected count is 4.50.
a. 
Group Statistics
50 2.62 .697 .099
50 2.28 .573 .081
50 139.10 10.771 1.523
50 144.70 8.830 1.249
GROUP
GROUP 1
GROUP 2
GROUP 1
GROUP 2
ONSET OF SENSORY
DURATION OF SENSORY
N Mean Std. Deviation
Std. Error
Mean
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T-Test 
Table 10 
 
GROUP1 GROUP2 
2.62 2.28 
 
 
Mean for onset of sensory block in group 1 is 2.62 and group 2 is 2.28;with 
mean difference 0.340 and P<0.01.So time taken for sensory block upto T10 
dermatomal level is earlier in ropivacaine group(Group 2). 
Independent Samples Test
7.408 .008 2.666 98 .009 .340 .128 .087 .593
2.666 94.474 .009 .340 .128 .087 .593
1.359 .247 -2.843 98 .005 -5.600 1.970 -9.509 -1.691
-2.843 94.371 .005 -5.600 1.970 -9.511 -1.689
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
ONSET OF SENSORY
DURATION OF SENSORY
F Sig.
Levene's Test for
Equality of Variances
t df Sig. (2-tailed)
Mean
Difference
Std. Error
Difference Lower Upper
95% Confidence
Interval of the
Difference
t-test for Equality of Means
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GROUP1 GROUP2 
139.1 144.7 
 
  
           Mean duration of sensory in group 1 is 139.10 and group 2 is 144.70 
with mean difference -5.6 and P<0.01.This shows duration of sensory block 
is  comparatively longer in ropivacaine (Group 2) than bupivacaine(Group 1). 
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MOTOR BLOCK 
            Time taken for onset and duration of motor block for patients in both 
groups are compared and subjected to student t test. 
                                                Table 11 
 
 
Table 12 
 
 
 
 
 
 
  
Group Statistics
50 4.86 .881 .125
50 5.24 .716 .101
50 140.50 11.260 1.592
50 98.30 7.257 1.026
GROUP
GROUP 1
GROUP 2
GROUP 1
GROUP 2
ONSET OF MOTOR
DURATION OF MOTOR
N Mean Std. Deviation
Std. Error
Mean
Independent Samples Test
2.427 .122 -2.367 98 .020 -.380 .161 -.699 -.061
-2.367 94.073 .020 -.380 .161 -.699 -.061
7.087 .009 22.275 98 .000 42.200 1.894 38.441 45.959
22.275 83.717 .000 42.200 1.894 38.432 45.968
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
ONSET OF MOTOR
DURATION OF MOTOR
F Sig.
Levene's Test for
Equality of Variances
t df Sig. (2-tailed)
Mean
Difference
Std. Error
Difference Lower Upper
95% Confidence
Interval of the
Difference
t-test for Equality of Means
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ONSET OF MOTOR BLOCKADE 
 
 
 
 
 
 
 
Mean value for onset of motor blockade  in group 1(bupivacaine) is 4.86 and 
group 2 (ropivacaine) is 5.24;with mean difference -0.380 and P<0.05.This 
shows onset of motor block is little earlier in bupivacaine group(Group 1). 
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GROUP1 GROUP2 
140.5 98.3 
 
        Mean duration of motor blockade in group 1 is 140.50 and group 2 is 
98.30 with mean difference 42.20 and P<0.001.This shows longer duration of 
motor blockade is provided by  bupivacaine (Group 1). 
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T-Test 
                                                       Table 13 
 
 
PULSE RATE 
           There was not much variation in pulse rate recordings between two 
groups. 
 
Group Statistics
50 78.48 5.040 .713
50 75.72 5.686 .804
50 76.62 6.758 .956
50 73.66 4.847 .685
50 72.72 7.437 1.052
50 71.04 6.957 .984
50 73.18 10.199 1.442
50 68.52 8.345 1.180
50 77.88 17.689 2.502
50 73.06 13.682 1.935
50 78.70 15.305 2.165
50 73.70 9.355 1.323
50 76.84 9.805 1.387
50 74.32 6.738 .953
50 75.84 5.538 .783
50 74.06 4.093 .579
50 75.76 4.470 .632
50 73.94 3.461 .489
50 75.92 4.444 .628
50 74.40 3.149 .445
50 76.40 4.204 .595
50 74.94 3.133 .443
50 76.82 3.607 .510
50 74.80 3.258 .461
GROUP
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
PR - BASELINE
PR - 1 MIN
PR - 3 MIN
PR - 5 MIN
PR - 10 MIN
PR - 15 MIN
PR - 30 MIN
PR - 45 MIN
PR - 60 MIN
PR - 75 MIN
PR - 90 MIN
PR - 120 MIN
N Mean Std. Deviation
Std. Error
Mean
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PULSE RATE 
GROUP1 GROUP2 
BASELINE 78.48 75.72 
1 MIN 76.62 73.66 
3 MIN 72.72 71.04 
5 MIN 73.18 68.52 
10 MIN 77.88 73.06 
15 MIN 78.7 73.7 
30 MIN 76.84 74.32 
45 MIN 75.84 74.06 
60 MIN 75.76 73.94 
75 MIN 75.92 74.4 
90 MIN 76.4 74.94 
120 MIN 76.82 74.8 
 
 
 P value for pulse rate at 1,3,5,10,15,30,45,60,75,90 and 120 mins lies 
between0.05 and 0.1-this implies no statistical significance.  
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T-Test 
Table 14 
 
SYSTOLIC BLOOD PRESSURE 
          Systolic blood pressures were normal (>100mmHg) in both groups and 
was not statistically significant. 
 
                                      
Group Statistics
50 124.40 13.413 1.897
50 127.04 13.144 1.859
50 118.84 10.880 1.539
50 122.88 11.329 1.602
50 110.88 7.805 1.104
50 115.80 10.224 1.446
50 106.04 7.746 1.095
50 112.96 10.327 1.460
50 107.60 8.816 1.247
50 111.84 9.578 1.354
50 108.04 7.725 1.092
50 112.12 9.514 1.345
50 109.96 6.707 .948
50 113.92 9.080 1.284
50 111.84 6.563 .928
50 115.88 9.271 1.311
50 114.40 7.384 1.044
50 118.76 9.432 1.334
50 117.04 8.104 1.146
50 121.48 9.912 1.402
50 118.96 9.296 1.315
50 124.16 10.512 1.487
50 122.16 10.100 1.428
50 126.64 10.995 1.555
GROUP
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
SBP - BASELINE
SBP - 1 MIN
SBP - 3 MIN
SBP - 5 MIN
SBP - 10 MIN
SBP - 15 MIN
SBP - 30 MIN
SBP - 45 MIN
SBP - 60 MIN
SBP - 75 MIN
SBP - 90 MIN
SBP - 120 MIN
N Mean Std. Deviation
Std. Error
Mean
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SYSTOLIC BLOOD PRESSURE 
GROUP1 GROUP2 
BASELINE 124.4 127.04 
1 MIN 118.84 122.88 
3 MIN 110.88 115.8 
5 MIN 106.04 112.96 
10 MIN 107.6 111.84 
15 MIN 108.04 112.12 
30 MIN 109.96 113.92 
45 MIN 111.84 115.88 
60 MIN 114.4 118.76 
75 MIN 117.04 121.48 
90 MIN 118.96 124.16 
120 MIN 122.16 126.64 
 
 
 P value for SBP at 1,3,5,10,15,30,45,60,75,90 and 120 mins lies 
between0.05 and 0.1-this implies no statistical significance. 
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T-Test 
Table 15 
 
DIASTOLIC BLOOD PRESSURE 
         The two groups had no significant difference in diastolic blood 
pressure. 
                                         
Group Statistics
50 80.04 6.934 .981
50 79.40 7.626 1.079
50 75.96 7.279 1.029
50 75.72 7.149 1.011
50 69.80 5.617 .794
50 71.00 6.145 .869
50 66.40 5.079 .718
50 68.72 6.866 .971
50 68.00 7.887 1.115
50 66.72 5.824 .824
50 67.28 6.296 .890
50 67.48 5.433 .768
50 68.72 4.691 .663
50 69.12 4.835 .684
50 70.48 4.344 .614
50 70.88 5.098 .721
50 72.44 4.413 .624
50 72.92 5.082 .719
50 74.92 5.364 .759
50 75.36 5.228 .739
50 76.88 5.968 .844
50 77.64 5.795 .820
50 79.20 6.047 .855
50 80.08 6.114 .865
GROUP
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
DBP - BASELINE
DBP - 1 MIN
DBP - 3 MIN
DBP - 5 MIN
DBP - 10 MIN
DBP - 15 MIN
DBP - 30 MIN
DBP - 45 MIN
DBP - 60 MIN
DBP - 75 MIN
DBP - 90 MIN
DBP - 120 MIN
N Mean Std. Deviation
Std. Error
Mean
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DIASTOLIC BLOOD PRESSURE 
GROUP1 GROUP2 
BASELINE 80.04 79.4 
1 MIN 75.96 75.72 
3 MIN 69.8 71 
5 MIN 66.4 68.72 
10 MIN 68 66.72 
15 MIN 67.28 67.48 
30 MIN 68.72 69.12 
45 MIN 70.48 70.88 
60 MIN 72.44 72.92 
75 MIN 74.92 75.36 
90 MIN 76.88 77.64 
120 MIN 79.2 80.08 
 
 
            P value for DBP at 1,3,5,10,15,30,45,60,75,90 and 120 mins lies 
between0.05 and 0.1-this implies no statistical significance.  
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MEAN ARTERIAL PRESSURE 
 
 
Table 16 
 
                                              
 
 
Group Statistics
50 94.52 8.252 1.167
50 95.28 9.015 1.275
50 90.16 8.019 1.134
50 91.30 8.140 1.151
50 83.40 5.817 .823
50 86.16 7.218 1.021
50 79.44 5.372 .760
50 83.52 7.476 1.057
50 81.74 8.921 1.262
50 81.62 6.524 .923
50 80.82 6.889 .974
50 82.34 6.435 .910
50 81.84 4.761 .673
50 84.02 5.895 .834
50 84.26 4.793 .678
50 85.84 5.950 .841
50 86.42 4.803 .679
50 88.22 6.052 .856
50 88.76 5.920 .837
50 90.82 6.216 .879
50 90.76 6.915 .978
50 93.08 6.809 .963
50 93.36 7.392 1.045
50 95.60 7.373 1.043
GROUP
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
MAP - BASELINE
MAP - 1 MIN
MAP - 3 MIN
MAP - 5 MIN
MAP - 10 MIN
MAP - 15 MIN
MAP - 30 MIN
MAP - 45 MIN
MAP - 60 MIN
MAP - 75 MIN
MAP - 90 MIN
MAP - 120 MIN
N Mean Std. Deviation
Std. Error
Mean
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GROUP I GROUP II 
BASELINE 94.52 95.28 
1 MIN 90.16 91.3 
3 MIN 83.4 86.16 
5 MIN 79.44 83.52 
10 MIN 81.74 81.62 
15 MIN 80.82 82.34 
30 MIN 81.84 84.02 
45 MIN 84.26 85.84 
60 MIN 86.42 88.22 
75 MIN 88.76 90.82 
90 MIN 90.76 93.08 
120 MIN 93.36 95.6 
 
             
 P value for MAP at 1,3,5,10,15,30,45,60,75,90 and 120 mins lies 
between0.05 and 0.1-this implies no statistical significance. 
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RESPIRATORY RATE 
 
 
Table 17 
 
 
                                        
 
Group Statistics
50 14.98 1.097 .155
50 14.60 1.088 .154
50 14.46 .579 .082
50 14.58 .992 .140
50 14.48 .614 .087
50 14.34 .688 .097
50 14.50 .647 .091
50 14.40 .606 .086
50 14.60 .700 .099
50 14.40 .606 .086
50 14.38 1.369 .194
50 14.26 .527 .075
50 14.58 .731 .103
50 14.26 .527 .075
50 14.62 .805 .114
50 14.32 .551 .078
50 14.66 .823 .116
50 14.42 .575 .081
50 16.70 14.061 1.989
50 14.18 .438 .062
50 14.70 .763 .108
50 14.20 .452 .064
50 14.74 .723 .102
50 14.32 .621 .088
GROUP
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
RR - BASELINE
RR - 1 MIN
RR - 3 MIN
RR - 5 MIN
RR - 10 MIN
RR - 15 MIN
RR - 30 MIN
RR - 45 MIN
RR - 60 MIN
RR - 75 MIN
RR - 90 MIN
RR - 120 MIN
N Mean Std. Deviation
Std. Error
Mean
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GROUP I GROUP II 
BASELINE 14.98 14.6 
1 MIN 14.46 14.58 
3 MIN 14.48 14.34 
5 MIN 14.5 14.4 
10 MIN 14.6 14.4 
15 MIN 14.38 14.26 
30 MIN 14.58 14.26 
45 MIN 14.62 14.32 
60 MIN 14.66 14.24 
75 MIN 16.7 14.18 
90 MIN 14.7 14.2 
120 MIN 14.74 14.32 
 
 
            P value for respiratory rate at 1,3,5,10,15,30,45,60,75,90 and 120 
mins lies between0.05 and 0.1-this implies no statistical significance. 
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OXYGEN SATURATION 
 
 
Table 18 
 
 
 
 
Group Statistics
50 98.98 .553 .078
50 99.00 .452 .064
50 99.02 .473 .067
50 99.04 .402 .057
50 98.68 .683 .097
50 99.02 .377 .053
50 98.88 .558 .079
50 98.98 .377 .053
50 98.94 .550 .078
50 98.96 .402 .057
50 99.02 .428 .061
50 98.96 .348 .049
50 98.84 .370 .052
50 99.00 .350 .049
50 98.92 .340 .048
50 98.98 .377 .053
50 98.86 .351 .050
50 98.96 .283 .040
50 98.92 .274 .039
50 98.96 .348 .049
50 98.90 .364 .052
50 99.02 .319 .045
50 98.94 .424 .060
50 99.00 .202 .029
GROUP
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
SpO2 - BASELINE
SpO2 - 1 MIN
SpO2 - 3 MIN
SpO2 - 5 MIN
SpO2 - 10 MIN
SpO2 - 15 MIN
SpO2 - 30 MIN
SpO2 - 45 MIN
SpO2 - 60 MIN
SpO2 - 75 MIN
SpO2 - 90 MIN
SpO2 - 120 MIN
N Mean Std. Deviation
Std. Error
Mean
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SPO2 GROUP I GROUP II 
BASELINE 98.98 99 
1 MIN 99.02 99.04 
3 MIN 98.68 99.02 
5 MIN 98.88 98.98 
10 MIN 98.94 98.96 
15 MIN 99.02 98.96 
30 MIN 98.84 99 
45 MIN 98.92 98.98 
60 MIN 98.86 98.96 
75 MIN 98.92 98.92 
90 MIN 98.9 96.9 
120 MIN 98.94 96.94 
 
 
            P value for SPO2 at 1,3,5,10,15,30,45,60,75,90 and 120 mins lies 
between0.05 and 0.1-this implies no statistical significance. 
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QUALITY OF ANALGESIA 
Table 19 
 
Table 20 
 
Group Statistics
50 .04 .198 .028
50 .02 .141 .020
50 .16 .370 .052
50 .04 .198 .028
50 1.06 .240 .034
50 .86 .452 .064
50 1.82 .482 .068
50 1.62 .490 .069
50 2.44 .611 .086
50 2.34 .479 .068
50 3.18 .941 .133
50 3.24 .591 .084
GROUP
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
GROUP 1
GROUP 2
VAS1
VAS2
VAS3
VAS4
VAS5
VAS6
N Mean Std. Deviation
Std. Error
Mean
Independent Samples Test
1.370 .245 .581 98 .562 .020 .034 -.048 .088
.581 88.683 .563 .020 .034 -.048 .088
19.085 .000 2.021 98 .046 .120 .059 .002 .238
2.021 74.887 .047 .120 .059 .002 .238
12.803 .001 2.763 98 .007 .200 .072 .056 .344
2.763 74.557 .007 .200 .072 .056 .344
5.381 .022 2.057 98 .042 .200 .097 .007 .393
2.057 97.971 .042 .200 .097 .007 .393
5.007 .028 .911 98 .365 .100 .110 -.118 .318
.911 92.648 .365 .100 .110 -.118 .318
10.941 .001 -.382 98 .703 -.060 .157 -.372 .252
-.382 82.464 .704 -.060 .157 -.373 .253
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
VAS1
VAS2
VAS3
VAS4
VAS5
VAS6
F Sig.
Levene's Test for
Equality of Variances
t df Sig. (2-tailed)
Mean
Difference
Std. Error
Difference Lower Upper
95% Confidence
Interval of the
Difference
t-test for Equality of Means
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POST OPERATIVE VISUAL ANALOGUE SCALE (1-6 HRS) 
 
GROUP1 GROUP2 
VAS1 0.04 0.02 
VAS2 0.16 0.04 
VAS3 1.06 0.86 
VAS4 1.82 1.62 
VAS5 2.44 2.34 
VAS6 3.18 3.24 
 
 
 
P value of 2nd,3rd and 4th  hrs are <0.05.-Significant. 
  
-1
0
1
2
3
4
5
VAS1 VAS2 VAS3 VAS4 VAS5 VAS6
M
EA
N
 
±
SD
COMPARISON BETWEEN GROUP1 AND GROUP 2 IN VAS
GROUP 1
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SIDE EFFECTS 
 Side effects observed during this study are hypotension and 
bradycardia. Hypotension was managed with Inj. Ephedrine 6 or 12mg iv stat 
as necessary. Bradycardia was managed with Inj. Atropine 0.6 mg iv stat. 
Table 21 
 
Table 22 
 
 P-value for Chi Square test is 0.515-Not significant. 
                                  
SIDE EFFECTS * GROUP  Crosstabulation
3 1 4
6.0% 2.0% 4.0%
4 2 6
8.0% 4.0% 6.0%
2 1 3
4.0% 2.0% 3.0%
41 46 87
82.0% 92.0% 87.0%
50 50 100
100.0% 100.0% 100.0%
Count
% within GROUP
Count
% within GROUP
Count
% within GROUP
Count
% within GROUP
Count
% within GROUP
Inj.Ephedrine 6
Inj.Atrop 0.6
Inj.Ephedrine 12
Nil
SIDE
EFFECTS
Total
GROUP 1 GROUP 2
GROUP
Total
Chi-Square Tests
2.287a 3 .515
2.353 3 .502
2.150 1 .143
100
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
6 cells (75.0%) have expected count less than 5. The
minimum expected count is 1.50.
a. 
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DISCUSSION 
 Elective endoscopic procedures can be satisfactorily done under both 
general anaesthesia and regional anaesthesia. Spinal anaesthesia is frequently 
used as a sole anaesthetic for procedures such as URSL, TURP, VL and 
OIU.It provides significant post operative analgesia. 
 Hyberbaric local anaesthetics are commonly used in subarachnoid 
block. But they cause significant hemodynamic changes in middle and 
elderly patients even with low concentrations. So  an isobaric solution is a 
better alternative. 
 Using an opioid as adjuvant with local anaesthetic reduces the dose of 
local anaesthetic and also provides good post operative pain relief. Fentanyl 
is  commonly used opioid additive. 
 So in this study we are comparing the effects of intrathecal low dose 
0.5% isobaric Bupivacaine with Fentanyl and 0.5% isobaric Ropivacaine 
with Fentanyl. 
 In our group 1 patients received intrathecal 11.25 mg of 0.5% isobaric 
Bupivacaine with 12.5 microgram Fentanyl  and group 2 patients received 
intrathecal 11.25 mg 0.5% isobaric Ropivacaine with 12.5 microgram 
Fentanyl. Onset and duration of sensory and motor blockade, hemodynamic 
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stability and quality of analgesia were observed and the paramaters are 
subjected to  ‘t test’. 
ONSET OF SENSORY AND MOTOR BLOCK 
ARTICLE 1 
 Acta Anaesthesiologica Scandinavica. 2005 Nov;49(10):1477-82.  
Compared the effects of intrathecal 10 mg of 0.5% plain (isobaric) 
bupivacaine and 10 mg of 0.5% plain ropivacaine with 15 microgram 
fentanyl in two groups and showed that time of onset of sensory and motor 
blockade is similar in both groups. 
ARTICLE 2 
 Mantouvalou M1   
          Compared the spinal effects of plain bupivacaine, ropivacaine and 
levobupivacaine in lower abdominal surgery and showed that the onset of 
motor block was significantly faster in the bupivacaine group compared with 
that in the ropivacaine group and almost the same of that in the 
levobupivacaine group (P < 0.05). 
 In our study  mean for onset of sensory block in group 1 is 2.62 and 
group 2 is 2.28 with mean difference 0.340 and P<0.01.So time taken for 
sensory block upto T10 dermatomal level is earlier in Ropivacaine 
group(Group 2). 
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 In our study mean for onset of motor block in group 1 is 4.86 and 
group 2 is 5.24 with mean difference -0.380 and P<0.05.This shows onset of 
motor block is little earlier in Bupivacaine group(Group 1). 
 
DURATION OF SENSORY BLOCK. 
 According to Article 1 characteristics of sensory block is similar in 
both Bupivacaine and Ropivacaine group. 
 In Article 2 Ropivacaine presented a shorter duration of both motor 
and sensory block than Bupivacaine and Levobupivacaine (P <0.05) 
          In our study mean duration of sensory block in group 1 is 139.10 and 
group 2 is 144.70 with mean difference -5.6 and P<0.01.This shows duration 
of sensory block is longer in Ropivacaine group(Group 2) than Bupivacaine 
(Group 1). 
DURATION OF MOTOR BLOCK. 
        In the above stated Article 1  duration of motor block is shorter in 
Ropivacaine group with median, 126 min; interquartile range, 93-162 min 
compared to Bupivacaine group (median, 126 min; interquartile range, 93-
162 min); difference between medians 71 mins with P=0.003. 
 Article 2 states that Ropivacaine presented a shorter duration of both 
motor and sensory block than Bupivacaine and Levobupivacaine (P <0.05%). 
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 In our study mean duration of motor in group 1 is 140.50 and group 2 
is 98.30 with mean difference 42.20 and P<0.001.This shows duration of 
motor block is longer in Bupivacaine group(Group 1). 
 
HEMODYNAMIC STABILITY 
 According to Article 1 hemodynamic changes were similar between 
bupivacaine and ropivacaine groups. 
          In our study P value for baseline pulse rate, MAP, respiratory rate, 
SPO2 are 0.012,0.661,0.085,0.843 respectively. P value for above parameters 
at 1,3,5,10,15,30,45,60,75,90 and 120 mins lies between0.05 and 0.1. So 
there were no significant hemodynamic changes observed between two 
groups. 
 
QUALITY OF ANALGESIA 
 Quality of analgesia is assessed by observing post operative visual 
analogue scale score at 1,2,3,4,5 and 6 hrs. There was no significant 
difference in pain experience in between two groups except in 2nd,3rd and 4th 
hrs. P value of these hrs are <0.05.Mean value for Ropivacaine group are less 
in these 2,3 and 4 hrs. So quality of analgesia is comparatively better in 
Ropivacaine group(Group 2). 
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 In group 1 side effects like hypotension and bradycardia were 
experienced by 5 and 4 patients respectively. In group 2 hypotension and 
bradycardia were experienced by 2 patients each. Incidence of hypotension 
and bradycardia is comparatively higher in bupivacaine group (Group 1). 
                                            
  
  
 
 
SUMMARY 
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SUMMARY 
 Our study was conducted in elective endoscopic procedures like   
Trans Urethral Resection of Prostate, Vesicolitholapaxy, Ureteroscopic Stone 
Lithotripsy and Optical Internal Urethrostomy. The duration of endoscopic 
urological procedures does not exceed 1-1 ½ hrs. Spinal anaesthesia is 
commonly used for these procedures.  
 In our study, both isobaric Bupivacaine and isobaric Ropivacaine with 
Fentanyl provided adequate level of sensory blockade (T10) but Bupivacaine 
provides longer duration of motor blockade. Recovery from motor blockade 
is comparatively faster in Ropivacaine group. 
 Both the drugs have lesser hemodynamic effects. Quality of analgesia 
in post operative period was comparatively better with Ropivacaine. 
           Fentanyl additive was used in both the groups and it reduces the dose 
of local aneasthetic. 
           Adverse effects like hypotension and bradycardia are fewer in both 
groups and are manageable. 
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CONCLUSION 
 We conclude from our study that low dose isobaric Ropivacaine with 
Fentanyl is a good alternative to isobaric Bupivacaine with Fentanyl  in 
endoscopic urological procedures .Ropivacaine provides  adequate level of 
sensory block and comparatively less duration of motor block which is 
enough for elective endoscopic urological procedures. This allows patients to 
ambulate early thereby reducing risks of venous stasis. It also provides good 
post operative pain relief. 
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